|
|
News Breaks
|
November 22, 2009
|
| 14:59 EDT |  | BMY |
| theflyonthewall.com: | FDA approves supplemental new drug application for Bristol-Myers's Abilify | | Bristol-Myers Squibb and Otsuka Pharmaceutical announced that the FDA has approved the supplemental New Drug Application for ABILIFY for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods. :theflyonthewall.com |
|
|
News For BMY From The Last 14 Days Check below for free stories on BMY the last two weeks.
There are 8 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 23:32 EDT | | BMY |
| | 05:32 EDT | | BMY |
| theflyonthewall.com: | Sanofi, Bristol-Myers collect damages in Plavix patent litigation with Apotex | | Sanofi (SNY) and Bristol-Myers Squibb (BMY) announced that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix, or clopidogrel bisulfate, patent infringement case against Apotex. This payment, which follows the decision of the U.S. Court of Appeals for the Federal Circuit in October 2011 upholding the payment of damages to the companies by Apotex, represents the final phase of the Plavix patent litigation between the companies and Apotex, which was initiated on March 21, 2002. Sanofi and Bristol-Myers Squibb were also awarded $1,258,682 in post-judgment interest and $900,000 in costs in addition to the damages award. :theflyonthewall.com |
|
|
February 3, 2012
|
| 07:31 EDT | | BMY |
| theflyonthewall.com: | Bristol-Myers announces expiration of waiting period for Inhibitex acquisition |
 Subscribe for More Information :theflyonthewall.com |
|
|
January 26, 2012
|
| 11:09 EDT |  | BMY |
| | 07:48 EDT |  | BMY |
| | 07:43 EDT | | BMY |
| theflyonthewall.com: | Bristol-Myers sees FY effective tax rate 25%-26% | | :theflyonthewall.com |
| | 07:43 EDT | | BMY |
| | 07:31 EDT | | BMY |
| theflyonthewall.com: | Bristol-Myers reports Q4 adjusted EPS 53c vs. consensus 55c | | Reports Q4 revenue $5.45B vs. consensus $5.51B. :theflyonthewall.com |
|
|
|
|
|
